MedTrace Logo

COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants

NCT04413968 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2020-10-26

No results posted yet for this study

Summary

According to epidemiological models, the seroprevalence of SARS-CoV-2 infection in Île-de-France as of 11 May was between 10 and 15%. Preliminary data on the number of professionals evicted from nurseries on suspicion of COVID-19 (on clinical grounds) seem to be of the same order of magnitude, but need to be confirmed by a biological technique. Children would be susceptible to infection but often asymptomatic.

Conditions

  • Coronavirus
  • Coronavirus Infection
  • Covid19
  • Sars-CoV2

Interventions

DIAGNOSTIC_TEST

Rapid detection test

Rapid serological test by taking 3 drops of blood from the fingertip via the TDR device (rapid detection test) for children, supervising nursery staff and hospital laboratory and administrative staff

DIAGNOSTIC_TEST

Nasopharyngeal swab

Posterior nasopharyngeal swabbing in children

DIAGNOSTIC_TEST

Stool collection

Stool collection in children

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Eric LACHASSINNE, MD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Month
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-02
Primary Completion
2020-07-02
Completion
2020-10-02

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04413968 on ClinicalTrials.gov